MyoKardia, Inc. Common Stock
MYOK
MYOK was delisted on the 16th of November, 2020.
194 hedge funds and large institutions have $2.3B invested in MyoKardia, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 73 increasing their positions, 60 reducing their positions, and 20 closing their positions.
90% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 20
22% more repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 60
9% more funds holding
Funds holding: 178 → 194 (+16)
9% more call options, than puts
Call options by funds: $67.9M | Put options by funds: $62.4M
11% less funds holding in top 10
Funds holding in top 10: 9 → 8 (-1)
36% less capital invested
Capital invested by funds: $3.62B → $2.3B (-$1.32B)
Top Buyers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$32.1M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$23.3M |
| 3 |
VC
Vivo Capital
Palo Alto,
California
|
+$21.4M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$16.2M |
| 5 |
Two Sigma Advisers
New York
|
+$13M |
Top Sellers
MYOK Hedge Fund Activity: Q1 2020 in Review
194 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in MyoKardia, Inc. Common Stock (MYOK) for Q1 2020, worth a combined $2.3B — down 36% from $3.62B a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new MYOK positions and 20 closed out — a net gain of 18 holders — while 73 added to existing stakes and 60 trimmed.
The largest buyer was Janus Henderson Group, adding an estimated $32.1M. The largest seller was Farallon Capital Management, cutting an estimated $104M.
- 194 institutional investors held MyoKardia, Inc. Common Stock (MYOK) as of Q1 2020, up from 178 in Q4 2019.
- Funds reported $2.3B of MyoKardia, Inc. Common Stock stock for Q1 2020, down 36% quarter-over-quarter.
- 38 funds opened new MyoKardia, Inc. Common Stock positions in Q1 2020 and 20 closed out, a net change of +18 holders.
- The largest MyoKardia, Inc. Common Stock buyer in Q1 2020 was Janus Henderson Group, an estimated $32.1M added.
- The largest MyoKardia, Inc. Common Stock seller in Q1 2020 was Farallon Capital Management, an estimated $104M sold.
Based on aggregated 13F filings for Q1 2020.